NovoCure Limited (NVCR)
收市後：
| 前收市價 | 17.59 |
| 開市 | 17.68 |
| 買盤 | 17.25 x 800 |
| 賣出價 | 17.52 x 800 |
| 今日波幅 | 17.25 - 17.78 |
| 52 週波幅 | 17.14 - 120.03 |
| 成交量 | |
| 平均成交量 | 1,783,561 |
| 市值 | 1.85B |
| Beta 值 (5 年，每月) | 0.61 |
| 市盈率 (最近 12 個月) | 無 |
| 每股盈利 (最近 12 個月) | -1.63 |
| 業績公佈日 | 2023年10月25日 - 2023年10月30日 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 58.71 |
Insider MonkeyShould You Hold NovoCure Limited (NVCR)?
ClearBridge Investments, an investment management company, released its “ClearBridge Small Cap Strategy” second quarter 2023 investor letter. A copy of the same can be downloaded here. The strategy outperformed the Russell 2000 Index in the second quarter. On an absolute basis, the strategy gained all 11 sectors it invested in during the quarter. IT and industrial […]
InvestorPlace3 Healthcare Stocks to Sell in September Before They Crash & Burn
The healthcare industry comprises multiple sectors, including biotechnology, pharmaceuticals, and healthcare equipment, each offering a unique and potentially risky opportunity. News regarding FDA approval and positive results for therapies, pharmaceuticals, and trials greatly influences the outlook for companies, especially ones with small market cap share price. Healthcare companies can see a massive surge in their share price, following encouraging treatment outcomes, but the reverse is also
Insider Monkey15 Worst Performing Healthcare Stocks in 2023
In this article, we discuss 15 worst performing healthcare stocks in 2023. If you want to skip our detailed discussion about the healthcare industry, head directly to 5 Worst Performing Healthcare Stocks in 2023. In 2021, healthcare spending in the United States accounted for over 18.3% of its GDP and the national healthcare expenditure came […]
